期刊文献+

靶控麻醉输注(TCI)得普利麻加瑞芬太尼诱导对抑制气管插管反应作用观察

Inhibitory Effects of Mixture of Propofol and Remifentanil by TCI on Tracheal Intubation Response
下载PDF
导出
摘要 目的探讨在使用术前用药前提下应用靶控输注得普利麻与瑞芬太尼混合液实施快诱导气管插管时的量效分析.方法采用Probit法计算得普利麻、瑞芬太尼ED50和ED95及95%的可信区间,通过转换为mg/kg找到二者混合时最佳剂量.结果应用Probit法计算ED50和ED95,得普利麻分别为0.70mg/kg(95%可信区间为0.63%~0.74%g)、1.03mg/kg(95%可信区间为0.94%~1.19%g).瑞芬太尼分别为1.39μg/kg(95%可信区间为1.27%~1.49%)、2.05μg/kg(95%可信区间为1.88%~2.37%).结论使用咪唑安定、哌替啶、氟哌利多作为术前用药前提下输注得普利麻与瑞芬太尼混合液实施快诱导气管插管能很好地抑制气管插管反应. Objective To investigate the dose-response relationship of the mixture of propofol and remifentanil by TCI for rapid induction before tracheal intubation under the condition of premedication,and to find the optimal dose of propofol and remifentanil when they are mixed.Methods The adult patients of both sexes,ASAⅠ~Ⅱ,aged 20~60 yr,were enrolled in the study.The patients were premedicated with midazolam,pethidine and droperidol.Anesthesia was rapidly induced with the mixture of propofol and remifentanil at a plasma concentration of 3.0 μg/mL.The BP,HR and intubation response were recorded.The Probit method was used to calculate the ED50 and ED95 of propofol and remifentanil,and the 95% confidence interval.Results The ED50 and ED95 was calculated using Probit method.The ED50 and ED95 of propofol were 0.70 mg/kg(95% confidence interval 0.63~0.74 mg/kg) and 1.03 mg/kg(95% confidence interval 0.94~1.19 mg/kg),respectively.The ED50 and ED95 of remifentanil were 1.39 μg/kg(95% confidence interval 1.27~1.49 μg/kg) and 2.05 μg/kg(95% confidence interval 1.88~2.37 μg/kg),respectively.Conclusion The intubation response can be inhibited effectively after rapid induction with the mixture of propofol and remifentanil under the condition of premedication with midazolam,pethidine and droperidol.
作者 邓新波
出处 《昆明医学院学报》 2010年第4期66-69,共4页 Journal of Kunming Medical College
关键词 药物释放系统 二异丙酚 哌啶类 插管法 气管内 药物 Drugdeliverysystems Propofol Piperidines Intubation Intratrachea Drug
  • 相关文献

参考文献5

二级参考文献9

  • 1薛昀,吴新民.靶控输注瑞芬太尼或芬太尼对术前病人异丙酚镇静作用的影响[J].中华麻醉学杂志,2005,25(10):729-732. 被引量:21
  • 2Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid:remifentanil (G187094B). Anesth Analg,1993, 77: 1031-1040.
  • 3Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg, 1999, 89 Suppl: s7-s14.
  • 4Jhavefi R, Joshi P, Batenhorst R, et al. Dose comparison of remifentanil and alfentanil for loss of consciousness. Anesthesiology, 1997, 87: 253-259.
  • 5Conway DH, Hasan SK, Simpson ME, et al. Target-contrelled propofol requirements at induction of anaesthesia: effect of remifentanil and midazolam.Eur J Anaestbesiol,2002.19:580-584.
  • 6Mertens MJ.Olofsen E.Enghers FH.et al.Propofol reduces perioperative remifentanil requirements in a synergiastic manner:response surface modeling of perioperative remifentanil-propofol interactions.Anesthesiology,2003.99:347-359.
  • 7Fragen RJ, Randel GI, Librojo ES, et al. The interaction of remifentanil and propofol to prevent response to tracheal intubation and the start of surgery for outpatient knee arthroscopy. Anesthesiology, 1994, 81:A376.
  • 8徐卉,田玉科,杨辉,王鹏.丙泊酚反馈靶控输注静脉麻醉与异氟醚吸入麻醉的临床效果比较[J].临床麻醉学杂志,2003,19(7):387-389. 被引量:37
  • 9耿志宇,许幸,吴新民.瑞芬太尼复合异丙酚靶控输注诱导时的量效关系[J].中华麻醉学杂志,2004,24(4):260-263. 被引量:181

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部